Summary includes data analysis
Reports provided in PDF format, RAW files available upon request
Typical 2 weeks from LC-MS/MS raw data acceptance to data report delivery
In recent years, research on gut related diseases has developed rapidly and it is now thought that nearly 90% of diseases may be related to gut microbiota health. Metagenome/16S + metabolome correlation analysis enables researchers to establish a correlation model between host metabolism and gut microbiota and explore the causal relationships between microbes and disease.
Note: Stools and intestinal contents samples are recommended for Metagenome/16S services; blood samples (serum, plasma) are recommended for Metabolome services. No biological correlation analysis for the differential metabolites and the differential species.
| NTEGRATIVE ANALYSIS | BIOLOGICAL DUPLICATES WHEN 2 GROUPS | BIOLOGICAL DUPLICATES WHEN ≥ 3 GROUPS |
|---|---|---|
| Metagenome + metabolome | ≥ 8 | ≥ 6 |
| 16S+ metabolome | ≥ 8 | ≥ 4 |
| Clinical samples | ≥ 30 | ≥ 30 |
BGI’s RNA Sequencing services are typically executed with proprietary DNBSEQ™ sequencing technology platforms, for great sequencing data at some of the lowest costs in the industry. DNBSEQ™ offers advantages in terms of lower amplification error rates and much lower duplication rates. In addition, studies have shown the lower index hopping rate in DNBSEQ™ platforms.
